← Back to all trials
Completed
NCT04031183
Population Pharmacokinetics of Metronidazole in Neonates
Conditions: Emergencies
Sex: All
Ages: N/A – 44 Weeks
Healthy volunteers: No
Enrollment: 171
Sponsor: Rennes University Hospital
Location: CHU d'Angers Angers
Summary
The objective of NEOPOPI is to conduct a population pharmacokinetic study of metronidazole in neonates, in order to evaluate and optimize neonatal dose regimen.
There will be no change to the medication treatment received by participants. An opportunistic pharmacokinetic sampling approach will be followed: samples will be scavenged from blood or cerebrospinal fluid drawn for routine biochemical tests. In this way, no additional invasive tests will be needed.
Eligibility Criteria
Inclusion Criteria:
* In case of birth at gestational age ≥ 37 weeks of amenorrhea (SA): inclusion of children of postnatal age \
Source: ClinicalTrials.gov (NCT04031183). StuddyBuddy aggregates publicly available trial information.
